[CLINICAL DATA ON THE USE OF A NEW SYNTHETIC ANTI-DYSREACTIVE AGENT IN THE PEDIATRIC FIELD].
D001168:Arthritis; D001172:Arthritis, Rheumatoid; D001249:Asthma; D001991:Bronchitis; D001996:Bronchopneumonia; D002648:Child; D004660:Encephalitis; D004893:Erythema Nodosum; D006801:Humans; D007223:Infant; D010113:Oxyphenbutazone; D010493:Pericarditis; D011051:Poliomyelitis; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal; D014397:Tuberculosis, Pulmonary
D010113:Oxyphenbutazone
ARTHRITIS, RHEUMATOID; ASTHMA; BRONCHITIS; BRONCHOPNEUMONIA; CHILD; ENCEPHALITIS; ERYTHEMA NODOSUM; INFANT; OXYPHENBUTAZONE; PERICARDITIS; POLIOMYELITIS; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, PULMONARY